Clinical pharmacology and determinates of response to gefitinib in non-small cell lung cancer
Clinical pharmacology and determinates of response to gefitinib in non-small cell lung cancer
About this item
Full title
Author / Creator
Publisher
Thousand Oaks, CA: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
Thousand Oaks, CA: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Objective. Provide a review and update of gefitinib (Iressa®), including recent data on mutations in the epidermal growth factor receptor (EGFR) and possible implications in non-small cell lung cancer patients.
Data sources. Primary literature and review articles were researched using Pub-Med. Articles through June 2004 were considered for prepa...
Alternative Titles
Full title
Clinical pharmacology and determinates of response to gefitinib in non-small cell lung cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_221227009
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_221227009
Other Identifiers
ISSN
1078-1552
E-ISSN
1477-092X
DOI
10.1191/1078155204jp130oa
